(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.08%) $79.06
(0.00%) $1.932
(0.87%) $2 331.10
(0.83%) $26.97
(0.97%) $964.20
(-0.46%) $0.933
(-0.65%) $11.02
(-0.32%) $0.798
(0.06%) $93.51
0.00% $ 33.97
Live Chart Being Loaded With Signals
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide...
Stats | |
---|---|
Dzisiejszy wolumen | 5.63M |
Średni wolumen | 686 607 |
Kapitalizacja rynkowa | 1.49B |
EPS | $0 ( 2023-05-04 ) |
Last Dividend | $0.125 ( 2019-02-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | 21.09 |
ATR14 | $0.299 (0.88%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-31 | Williams Felicia | Sell | 10 274 | Common Stock |
2023-01-31 | Williams Felicia | Sell | 12 000 | Stock Option (Right to Buy) |
2023-01-31 | Williams Felicia | Sell | 8 740 | Stock Option (Right to Buy) |
2023-01-31 | Williams Felicia | Sell | 17 205 | Stock Option (Right to Buy) |
2023-01-31 | Williams Felicia | Sell | 5 796 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-88.83 |
Last 100 transactions |
Buy: 118 571 | Sell: 1 534 678 |
Wolumen Korelacja
Meridian Bioscience Inc Korelacja
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Meridian Bioscience Inc Korelacja - Waluta/Towar
Meridian Bioscience Inc Finanse
Annual | 2022 |
Przychody: | $333.02M |
Zysk brutto: | $188.36M (56.56 %) |
EPS: | $0.960 |
FY | 2022 |
Przychody: | $333.02M |
Zysk brutto: | $188.36M (56.56 %) |
EPS: | $0.960 |
FY | 2021 |
Przychody: | $317.90M |
Zysk brutto: | $201.15M (63.27 %) |
EPS: | $1.650 |
FY | 2020 |
Przychody: | $253.67M |
Zysk brutto: | $156.25M (61.60 %) |
EPS: | $1.080 |
Financial Reports:
No articles found.
Meridian Bioscience Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.00678 | 1990-11-29 |
Last Dividend | $0.125 | 2019-02-01 |
Next Dividend | $0 | N/A |
Payout Date | 2019-02-14 | |
Next Payout Date | N/A | |
# dividends | 114 | -- |
Total Paid Out | $9.88 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.53 | -- |
Div. Sustainability Score | 0.950 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.115 | -- |
Year | Amount | Yield |
---|---|---|
1990 | $0 | 0.00% |
1991 | $0 | 0.00% |
1992 | $0 | 0.00% |
1993 | $0 | 0.00% |
1994 | $0 | 0.00% |
1995 | $0 | 0.00% |
1996 | $0 | 0.00% |
1997 | $0 | 0.00% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0.160 | 3.50% |
2004 | $0.178 | 3.83% |
2005 | $0.213 | 2.70% |
2006 | $0.307 | 2.09% |
2007 | $0.434 | 2.63% |
2008 | $0.560 | 1.88% |
2009 | $0.680 | 2.60% |
2010 | $0.760 | 3.51% |
2011 | $0.760 | 3.21% |
2012 | $0.950 | 4.98% |
2013 | $0.570 | 2.75% |
2014 | $0.800 | 3.06% |
2015 | $0.800 | 4.88% |
2016 | $0.800 | 4.10% |
2017 | $0.500 | 2.80% |
2018 | $0.500 | 3.47% |
2019 | $0.125 | 0.74% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.197 | 1.500 | -3.93 | -5.90 | [0 - 0.5] |
returnOnAssetsTTM | -0.0528 | 1.200 | -1.760 | -2.11 | [0 - 0.3] |
returnOnEquityTTM | -0.0681 | 1.500 | -1.867 | -2.80 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.56 | 0.800 | 2.18 | 1.741 | [1 - 3] |
quickRatioTTM | 1.472 | 0.800 | 6.05 | 4.84 | [0.8 - 2.5] |
cashRatioTTM | 0.943 | 1.500 | 5.87 | 8.81 | [0.2 - 2] |
debtRatioTTM | 0.0682 | -1.500 | 8.86 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -65.48 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.00825 | 2.00 | -0.00275 | -0.00550 | [0 - 30] |
freeCashFlowPerShareTTM | -0.148 | 2.00 | -0.0740 | -0.148 | [0 - 20] |
debtEquityRatioTTM | 0.0914 | -1.500 | 9.63 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.534 | 1.000 | 4.43 | 4.43 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.197 | 1.000 | -5.93 | -5.93 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.0116 | 1.000 | -1.176 | -1.176 | [0.2 - 2] |
assetTurnoverTTM | 0.268 | 0.800 | -1.544 | -1.235 | [0.5 - 2] |
Total Score | 0.950 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -61.83 | 1.000 | -6.35 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0681 | 2.50 | -1.200 | -2.80 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.148 | 2.00 | -0.0493 | -0.148 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.00825 | 2.00 | -0.00275 | -0.00550 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.518 | 1.500 | 3.22 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.00295 | 1.000 | -2.57 | 0 | [0.1 - 0.5] |
Total Score | -0.720 |
Meridian Bioscience Inc
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej